Article info
PostScript
Letter
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
- Correspondence to Dr Sara Mariotto, Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Verona 37134, Italy; sara.mariotto{at}gmail.com
Citation
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
Publication history
- Received December 28, 2018
- Revised March 6, 2019
- Accepted March 9, 2019
- First published April 5, 2019.
Online issue publication
December 12, 2019
Article Versions
- Previous version (10 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.